Differences in management approaches for lupus nephritis within the UK
Sara T. Ibrahim(University of Birmingham), John A. Reynolds(Manchester Academic Health Science Centre), Benjamin Rhodes(University Hospitals Birmingham NHS Foundation Trust), Zoe McLaren(University of Liverpool), Edward M Vital(University of Leeds), Peter Hewins, Caroline Gordon(University of Birmingham), Michael R. Ehrenstein, David Jayne(University of Cambridge), Liz Lightstone(Imperial College London), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Bridget Griffiths(Freeman Hospital)
Cited by 6
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k